Building Biotechnology at #BIO2014
I will be signing copies of my textbook, Building Biotechnology from 3pm-4:30pm in Lobby D at BIO2014. Feel free to […]
I will be signing copies of my textbook, Building Biotechnology from 3pm-4:30pm in Lobby D at BIO2014. Feel free to […]
I am seeking input on a new project which helps you identify top-performing patent attorneys. PatentStat.com uses cutting-edge research on patent
PatentStat – Find top-performing patent attorneys Read Post »
I continue to measure global biotechnology innovation in the sixth edition of Scientific American Worldview. This special publication is the foundation
Scientific American Worldview Issue 6 at #BIO2014 Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ABSTRACT:
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
For more information, see the Journal of Commercial Biotechnology website
Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference Read Post »
My paper on global biopharmaceutical productivity has been published in the latest issue of Nature Biotechnology. This paper is a
The nature of Asian biopharmaceutical innovation Read Post »
MassBio and the Journal of Commercial Biotechnology have partnered to provide MassBio members with free and discounted subscriptions. New MassBio members can get a free
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The European Commission has launched a public consultation on its proposed amendments to the Medical De…
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
What changes will India's next Prime Minister bring to India's Innovative Life Sciences? Read Post »
BIOTECanada and the Journal of Commercial Biotechnology have partnered to provide BIOTECanada members with free and discounted subscriptions. New BIOTECanada
Stem cells are a rapidly developing technology area. The pace of scientific and clinical progress is accompanied by new patents,
Track new stem cell innovations with StemCellPatentWatch Read Post »